Startups
RelieVRx (formerly EaseVRx) is an FDA-authorized at-home immersive virtual reality (VR) pain treatment indicated as adjunctive treatment for chronic lower back pain (CLBP). It is clinically demonstrated to decrease pain severity and pain interference in the lives of patients experiencing CLBP. RelieVRx promotes neuroplasticity and enables patients to build long-term skills to respond to pain.
RelieVRx is the first comprehensive, immersive adjunctive VR treatment for chronic pain to ever be FDA-authorized. It offers an immersive eight-week virtual reality experience that helps patients adjust their cognitive, emotional and physical responses to chronic pain.
AppliedVR is the developer of RelieVRx. Some of RelieVRx’s competitors include Ultraleap, Lost Horizon, Occipital and Yeltic.
RelieVRx is the first comprehensive, immersive adjunctive VR treatment for chronic pain to ever be FDA-authorized. It offers an immersive eight-week virtual reality experience that helps patients adjust their cognitive, emotional and physical responses to chronic pain.
AppliedVR is the developer of RelieVRx. Some of RelieVRx’s competitors include Ultraleap, Lost Horizon, Occipital and Yeltic.